Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 243568, 12 pages
http://dx.doi.org/10.1155/2013/243568
Review Article

Adjunct Methods of the Standard Diabetic Foot Ulceration Therapy

1Department of General and Gastrointestinal Surgery, Silesian Medical University, 41-902 Bytom Katowice, Poland
2Department of Internal Medicine, Silesian Medical University, 41-902 Bytom Katowice, Poland
3Department of Biochemistry, Silesian Medical University, 41-800 Zabrze Katowice, Poland

Received 5 February 2013; Revised 13 May 2013; Accepted 29 May 2013

Academic Editor: Wen-Chin Yang

Copyright © 2013 Dariusz Waniczek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. IDF Diabetes Atlas, 5th edition, 2012.
  2. B. Bruhn-Olszewska, A. Korzon-Burakowska, M. Gabig-Cimińska, P. Olszewski, A. Wegrzyn, and J. Jakóbkiewicz-Banecka, “Molecular factors involved in the development of diabetic foot syndrome,” Acta Biochimica Polonica, vol. 59, no. 4, pp. 507–513, 2012. View at Google Scholar
  3. S. Cornell and V. J. Dorsey, “Diabetes pharmacotherapy in 2012: considerations in medication selection,” Postgraduate Medicine, vol. 124, pp. 84–94, 2012. View at Publisher · View at Google Scholar
  4. M. M. Iversen, An Epidemiologic Study of Diabetes-Related Foot Ulcers, Department of Public Health and Primary Health Care, Bergen, Norway, 2009.
  5. H. Brem, P. Sheehan, and A. J. M. Boulton, “Protocol for treatment of diabetic foot ulcers,” The American Journal of Surgery, vol. 187, no. 5, pp. 1–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Krishnan, F. Nash, N. Baker, D. Fowler, and G. Rayman, “Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit,” Diabetes Care, vol. 31, no. 1, pp. 99–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Bolton, P. McNees, L. van Rijswijk et al., “Wound-healing outcomes using standardized assessment and care in clinical practice,” Journal of Wound, Ostomy, and Continence Nursing, vol. 31, no. 2, pp. 65–71, 2004. View at Google Scholar · View at Scopus
  8. A. J. M. Boulton, P. R. Cavanagh, and G. Rayman, The Foot in Diabetes, John Wiley & Sons, New York, NY, USA, 4th edition, 2006.
  9. N. Singh, D. G. Armstrong, and B. A. Lipsky, “Preventing foot ulcers in patients with diabetes,” The Journal of the American Medical Association, vol. 293, no. 2, pp. 217–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. M. Boulton, “The pathogenesis of diabetic foot problems: an overview,” Diabetic Medicine, vol. 13, no. 1, pp. S12–S16, 1996. View at Google Scholar · View at Scopus
  11. A. Ndip and E. B. Jude, “Emerging evidence for neuroischemic diabetic foot ulcers: model of care and how to adapt practice,” International Journal of Lower Extremity Wounds, vol. 8, no. 2, pp. 82–94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Ribu, B. R. Hanestad, T. Moum, K. Birkeland, and T. Rustoen, “A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population,” Quality of Life Research, vol. 16, no. 2, pp. 179–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Ramsey, K. Newton, D. Blough et al., “Incidence, outcomes, and cost of foot ulcers in patients with diabetes,” Diabetes Care, vol. 22, no. 3, pp. 382–387, 1999. View at Google Scholar · View at Scopus
  14. K. Bakker, J. Apelqvist, and N. C. Schaper, “Practical guidelines on the management and prevention of the diabetic foot 2011,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 225–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. F. W. Wagner Jr., “The dysvascular foot: a system for diagnosis and treatment,” Foot and Ankle, vol. 2, no. 2, pp. 64–122, 1981. View at Google Scholar · View at Scopus
  16. L. A. Lavery, “Effectiveness and safety of elective surgical procedures to improve wound healing and reduce re-ulceration in diabetic patients with foot ulcers,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 60–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Baroni, T. Porro, E. Faglia et al., “Hyperbaric oxygen in diabetic gangrene treatment,” Diabetes Care, vol. 10, no. 1, pp. 81–86, 1987. View at Google Scholar · View at Scopus
  18. W. A. Zamboni, H. P. Wong, L. L. Stephenson, and M. A. Pfeifer, “Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study,” Undersea and Hyperbaric Medicine, vol. 24, no. 3, pp. 175–179, 1997. View at Google Scholar · View at Scopus
  19. E. Faglia, F. Favales, A. Aldeghi et al., “Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation,” Journal of Diabetes and Its Complications, vol. 12, no. 2, pp. 96–102, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Faglia, F. Favales, A. Aldeghi et al., “Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer: a randomized study,” Diabetes Care, vol. 19, no. 12, pp. 1338–1343, 1996. View at Google Scholar · View at Scopus
  21. S. R. Thom, “Hyperbaric oxygen: its mechanisms and efficacy,” Plastic and Reconstructive Surgery, vol. 127, no. 1, pp. 131–141, 2011. View at Publisher · View at Google Scholar
  22. J. J. Feldmeier and N. B. Hampson, “A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach,” Undersea and hyperbaric Medicine, vol. 29, no. 1, pp. 4–30, 2002. View at Google Scholar
  23. J. H. A. Niinikoski, “Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry,” World Journal of Surgery, vol. 28, no. 3, pp. 307–311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. N. B. Ackerman and F. B. Brinkley, “Oxygen tensions in normal and ischemic tissues during hyperbaric therapy. Studies in rabbits,” The Journal of the American Medical Association, vol. 198, no. 12, pp. 1280–1283, 1966. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Löndahl, P. Katzman, C. Hammarlund, A. Nilsson, and M. Landin-Olsson, “Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers,” Diabetologia, vol. 54, no. 1, pp. 65–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Heinzelmann, M. Scott, and T. Lam, “Factors predisposing to bacterial invasion and infection,” The American Journal of Surgery, vol. 183, no. 2, pp. 179–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. T. Mader, G. L. Brown, J. C. Guckian, C. H. Wells, and J. A. Reinarz, “A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits,” Journal of Infectious Diseases, vol. 142, no. 6, pp. 915–922, 1980. View at Google Scholar · View at Scopus
  28. M. C. Heng, J. Harker, G. Csathy et al., “Angiogenesis in necrotic ulcers treated with hyperbaric oxygen,” Ostomy/Wound Management, vol. 46, no. 9, pp. 18–32, 2000. View at Google Scholar · View at Scopus
  29. S. R. Thom, T. N. Milovanova, M. Yang et al., “Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: Increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy,” Wound Repair and Regeneration, vol. 19, no. 2, pp. 149–161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Ramon, A. Abramovich, A. Shupak et al., “Effect of hyperbaric oxygen on a rat transverse rectus abdominis myocutaneous flap model,” Plastic and Reconstructive Surgery, vol. 102, no. 2, pp. 416–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. C. T. Selçuk, S. V. Kuvat, M. Bozkurt et al., “The effect of hyperbaric oxygen therapy on the survival of random pattern skin flaps in nicotine-treated rats,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 65, no. 4, pp. 489–493, 2012. View at Publisher · View at Google Scholar
  32. P. Kranke, M. Bennett, I. Roeckl-Wiedmann, and S. E. Debus, “Hyperbaric oxygen therapy for chronic wounds,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004123, 2004. View at Google Scholar · View at Scopus
  33. M. Löndahl, P. Katzman, A. Nilsson, and C. Hammarlund, “Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes,” Diabetes Care, vol. 33, no. 5, pp. 998–1003, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Duzgun, H. Z. Satir, O. Ozozan, B. Saylam, B. Kulah, and F. Coskun, “Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers,” Journal of Foot and Ankle Surgery, vol. 47, no. 6, pp. 515–519, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Abidia, G. Laden, G. Kuhan et al., “The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomized-controlled trial,” European Journal of Vascular and Endovascular Surgery, vol. 25, no. 6, pp. 513–518, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kalani, G. Jörneskog, N. Naderi, F. Lind, and K. Brismar, “Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers—long-term follow-up,” Journal of Diabetes and Its Complications, vol. 16, no. 2, pp. 153–158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Doctor, S. Pandya, and A. Supe, “Hyperbaric oxygen therapy in diabetic foot,” Journal of Postgraduate Medicine, vol. 38, no. 3, pp. 112–111, 1992. View at Google Scholar · View at Scopus
  38. G. Oriani, D. Meazza, F. Favales et al., “Hyperbaric oxygen in diabetic gangrene,” Journal of Hyperbaric Medicine, vol. 5, pp. 171–175, 1990. View at Google Scholar
  39. C. Hammarlund and T. Sundberg, “Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study,” Plastic and Reconstructive Surgery, vol. 93, no. 4, pp. 829–833, 1994. View at Google Scholar · View at Scopus
  40. K. C. Lyon, “The case for evidence in wound care: investigating advanced treatment modalities in healing chronic diabetic lower extremity wounds,” Journal of Wound Ostomy and Continence Nursing, vol. 35, no. 6, pp. 585–590, 2008. View at Google Scholar
  41. R. P. Wunderlich, E. J. G. Peters, and L. A. Lavery, “Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot,” Diabetes Care, vol. 23, no. 10, pp. 1551–1555, 2000. View at Google Scholar · View at Scopus
  42. P. E. Prete, “Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy,” Life Sciences, vol. 60, no. 8, pp. 505–510, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Gupta, “A review of the use of maggots in wound therapy,” Annals of Plastic Surgery, vol. 60, no. 2, pp. 224–227, 2008. View at Publisher · View at Google Scholar
  44. G. Jarczyk, M. Jackowski, K. Szpila, G. Boszek, and S. Kapelaty, “Use of Lucilia sericata blowfly maggots in the treatment of diabetic feet threatened with amputation,” Acta Angiologica, vol. 14, no. 2, pp. 42–55, 2008. View at Google Scholar · View at Scopus
  45. R. A. Sherman, “Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy,” Diabetes Care, vol. 26, no. 2, pp. 446–451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. D. G. Armstrong, P. Salas, B. Short et al., “Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days,” Journal of the American Podiatric Medical Association, vol. 95, no. 3, pp. 254–257, 2005. View at Google Scholar · View at Scopus
  47. F. L. Bowling, E. V. Salgami, and A. J. M. Boulton, “Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers,” Diabetes Care, vol. 30, no. 2, pp. 370–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. D. C. W. Chan, D. H. F. Fong, J. Y. Y. Leung, N. G. Patil, and G. K. K. Leung, “Maggot debridement therapy in chronic wound care,” Hong Kong Medical Journal, vol. 13, no. 5, pp. 382–386, 2007. View at Google Scholar · View at Scopus
  49. F. L. Game, R. J. Hinchliffe, J. Apelqvist et al., “A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes,” Diabetes/Metabolism Research and Reviews, vol. 28, no. 1, pp. 119–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Ross, J. Glomset, B. Kariya, and L. Harker, “A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 4, pp. 1207–1210, 1974. View at Google Scholar · View at Scopus
  51. E. Cenni, G. Ciapetti, S. Pagani, F. Perut, A. Giunti, and N. Baldini, “Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts,” Journal of Periodontology, vol. 76, no. 3, pp. 323–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. L. R. Kark, J. M. Karp, and J. E. Davies, “Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions,” Clinical Oral Implants Research, vol. 17, no. 3, pp. 321–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Borzini and I. Mazzucco, “Platelet-rich plasma (PRP) and platelet derivatives for topical therapy. What is true from the biologic view point?” ISBT Science Series, vol. 2, no. 1, pp. 272–281, 2007. View at Publisher · View at Google Scholar
  54. D. R. Knighton, K. F. Ciresi, V. D. Fiegel, L. L. Austin, and E. L. Butler, “Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF),” Annals of Surgery, vol. 204, no. 3, pp. 322–330, 1986. View at Google Scholar · View at Scopus
  55. G. Pietramaggiori, S. S. Scherer, J. C. Mathews et al., “Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model,” Wound Repair and Regeneration, vol. 16, no. 2, pp. 218–225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. D. R. Knighton, T. K. Hunt, K. K. Thakral, and W. H. Goodson III, “Role of platelets and fibrin in the healing sequence. An in vivo study of angiogenesis and collagen synthesis,” Annals of Surgery, vol. 196, no. 4, pp. 379–388, 1982. View at Google Scholar · View at Scopus
  57. W. C. Krupski, L. M. Reilly, S. Perez, K. M. Moss, P. A. Crombleholme, and J. H. Rapp, “A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report,” Journal of Vascular Surgery, vol. 14, no. 4, pp. 526–536, 1991. View at Publisher · View at Google Scholar · View at Scopus
  58. D. J. Margolis, J. Kantor, J. Santanna, B. L. Strom, and J. A. Berlin, “Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers,” Diabetes Care, vol. 24, no. 3, pp. 483–488, 2001. View at Google Scholar · View at Scopus
  59. J. P. McAleer, S. Sharma, E. M. Kaplan, and G. Persich, “Use of autologous platelet concentrate in a nonhealing lower extremity wound,” Advances in Skin & Wound Care, vol. 19, no. 7, pp. 354–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. V. R. Driver, J. Hanft, C. P. Fylling, J. M. Beriou, and Autologel Diabetic Foot Ulcer Study Group, “A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers,” Ostomy/Wound Management, vol. 52, no. 6, pp. 68–74, 2006. View at Google Scholar · View at Scopus
  61. A. Gandhi, C. Doumas, J. P. O'Connor, J. R. Parsons, and S. S. Lin, “The effects of local platelet rich plasma delivery on diabetic fracture healing,” Bone, vol. 38, no. 4, pp. 540–546, 2006. View at Publisher · View at Google Scholar
  62. C. L. Scimeca, M. Bharara, T. K. Fisher, H. Kimbriel, and D. G. Armstrong, “Novel use of platelet-rich plasma to augment curative diabetic foot surgery,” Journal of Diabetes Science and Technology, vol. 4, no. 5, pp. 1121–1126, 2010. View at Google Scholar · View at Scopus
  63. D. L. Villela and V. L. C. G. Santos, “Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review,” Growth Factors, vol. 28, no. 2, pp. 111–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. R. G. Frykberg, V. R. Driver, D. Carman et al., “Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series,” Ostomy/Wound Management, vol. 56, no. 6, pp. 36–44, 2010. View at Google Scholar · View at Scopus
  65. M. J. Carter, C. P. Fylling, and L. K. Parnell, “Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis,” Eplasty, vol. 11, article e38, 2011. View at Google Scholar
  66. J. M. de Leon, V. R. Driver, C. P. Fylling et al., “The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel,” Advances in Skin & Wound Care, vol. 24, no. 8, pp. 357–368, 2011. View at Google Scholar · View at Scopus
  67. T. Slesaczeck, H. Paetzold, T. Nanning et al., “Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report,” Therapeutic Advances in Endocrinology and Metabolism, vol. 3, no. 2, pp. 75–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Kessler, P. Bilbault, F. Ortéga et al., “Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers a prospective randomized study,” Diabetes Care, vol. 26, no. 8, pp. 2378–2382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. I. Roeckl-Wiedmann, M. Bennett, and P. Kranke, “Systematic review of hyperbaric oxygen in the management of chronic wounds,” The British Journal of Surgery, vol. 92, no. 1, pp. 24–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Löndahl, M. Landin-Olsson, and P. Katzman, “Hyperbaric oxygen therapy improves health-related quality of life in patients with diabetes and chronic foot ulcer,” Diabetic Medicine, vol. 28, no. 2, pp. 186–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Löndahl, “Hyperbaric oxygen therapy as treatment of diabetic foot ulcers,” Diabetes/Metabolism Research and Reviews, vol. 28, supplement1, pp. 78–84, 2012. View at Google Scholar
  72. R. Liu, L. Li, M. Yang, G. Boden, and G. Yang, “Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers,” Mayo Clinic Proceedings, vol. 88, no. 2, pp. 166–175, 2013. View at Publisher · View at Google Scholar
  73. W. J. Jeffcoate, “Wound healing-a practical algorithm,” Diabetes/Metabolism Research and Reviews, vol. 28, supplement 1, pp. 85–88, 2012. View at Google Scholar
  74. K. A. Gordon, E. A. Lebrun, M. Tomic-Canic, and R. S. Kirsner, “The role of surgical debridement in healing of diabetic foot ulcers,” Skinmed, vol. 10, no. 1, pp. 24–26, 2012. View at Google Scholar · View at Scopus
  75. M. J. A. van der Plas, M. Baldry, J. T. van Dissel, G. N. Jukema, and P. H. Nibbering, “Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP,” Diabetologia, vol. 52, no. 9, pp. 1962–1970, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. R. A. Sherman, “Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century,” Journal of Diabetes Science and Technology, vol. 3, no. 2, pp. 336–344, 2009. View at Google Scholar · View at Scopus
  77. K. Y. Mumcuoglu, J. Miller, M. Mumcuoglu, M. Friger, and M. Tarshis, “Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae),” Journal of Medical Entomology, vol. 38, no. 2, pp. 161–166, 2001. View at Google Scholar · View at Scopus
  78. K. C. Jiang, X. J. Sun, W. Wang et al., “Excretions/secretions from bacteria-pretreated maggot are more effective against Pseudomonas aeruginosa biofilms,” PloS ONE, vol. 7, no. 11, Article ID e49815, 2012. View at Publisher · View at Google Scholar
  79. S. Arora, C. Baptista, and C. S. Lim, “Maggot metabolites and their combinatory effects with antibiotic on Staphylococcus aureus,” Annals of Clinical Microbiology and Antimicrobials, vol. 10, article 6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Courtenay, J. C. T. Church, and T. J. Ryan, “Larva therapy in wound management,” Journal of the Royal Society of Medicine, vol. 93, no. 2, pp. 72–74, 2000. View at Google Scholar · View at Scopus
  81. J. C. Dumville, G. Worthy, J. M. Bland et al., “Larval therapy for leg ulcers (VenUS II): randomised controlled trial,” The British Medical Journal, vol. 338, article b773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Y. Mumcuoglu, “Clinical applications for maggots in wound care,” The American Journal of Clinical Dermatology, vol. 2, no. 4, pp. 219–227, 2001. View at Google Scholar · View at Scopus
  83. G. Y. Li, J.M. Yin, H. Ding, W. T. Jia, and C. Q. Zhang, “Efficacy of leukocyte-and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model,” Journal of Orthopaedic Research, vol. 31, no. 6, pp. 946–956, 2013. View at Publisher · View at Google Scholar
  84. F. Gottrup and B. Jorgensen, “Maggot debridement: an alternative method for debridement,” Journal of Plastic Surgery, vol. 11, pp. 290–300, 2011. View at Google Scholar
  85. W. S. Baer, “Treatment of chronic osteomyelitis with the maggot (larve of the blowfly),” Journal of Bone and Joint Surgery, vol. 13, no. 3, pp. 438–475, 1931. View at Google Scholar
  86. A. G. Paul, N. W. Ahmad, H. Lee et al., “Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers,” International Wound Journal, vol. 6, no. 1, pp. 39–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. A. G. Paul, N. W. Ahmad, H. Lee et al., “Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers,” International Wound Journal, vol. 6, no. 1, pp. 39–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. J. C. Dumville, G. Worthy, J. M. Bland et al., “Larval therapy for leg ulcers (VenUS II): randomised controlled trial,” The British Medical Journal, vol. 338, article b773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. R. A. Sherman, J. Sherman, L. Gilead, M. Lipo, and K. Y. Mumcuoglu, “Maggot débridement therapy in outpatients,” Archives of Physical Medicine and Rehabilitation, vol. 82, no. 9, pp. 1226–1229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. M. O. Soares, C. P. Iglesias, J. M. Bland et al., “Cost effectiveness analysis of larval therapy for leg ulcers,” The British Medical Journal, vol. 338, article b825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Nigam, A. Bexfield, S. Thomas, and N. A. Ratcliffe, “Maggot therapy: the science and implication for CAM Part I—history and bacterial resistance,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 223–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. S. Mehta and J. T. Watson, “Platelet rich concentrate: basic science and current clinical applications,” Journal of Orthopaedic Trauma, vol. 22, no. 6, pp. 433–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Heldin and B. Westermark, “Mechanism of action and in vivo role of platelet-derived growth factor,” Physiological Reviews, vol. 79, no. 4, pp. 1283–1316, 1999. View at Google Scholar · View at Scopus
  94. A. Gandhi, C. Bibbo, M. Pinzur, and S. S. Lin, “The role of platelet-rich plasma in foot and ankle surgery,” Foot and Ankle Clinics, vol. 10, no. 4, pp. 621–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. P. A. M. Everts, C. B. Mahoney, J. J. M. L. Hoffmann et al., “Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release,” Growth Factors, vol. 24, no. 3, pp. 165–171, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. P. A. M. Everts, J. Hoffmann, G. Weibrich et al., “Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation,” Transfusion Medicine, vol. 16, no. 5, pp. 363–368, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. R. E. Marx, “Platelet-rich plasma: evidence to support its use,” Journal of Oral and Maxillofacial Surgery, vol. 62, no. 4, pp. 489–496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. T. M. Bielecki, T. S. Gazdzik, J. Arendt, T. Szczepanski, W. Król, and T. Wielkoszynski, “Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study,” Journal of Bone and Joint Surgery B, vol. 89, no. 3, pp. 417–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. K. M. Lacci and A. Dardik, “Platelet-rich plasma: support for its use in wound healing,” Yale Journal of Biology and Medicine, vol. 83, no. 1, pp. 1–9, 2010. View at Google Scholar · View at Scopus
  100. C. Heldin and B. Westermark, “Mechanism of action and in vivo role of platelet-derived growth factor,” Physiological Reviews, vol. 79, no. 4, pp. 1283–1316, 1999. View at Google Scholar · View at Scopus
  101. A. Gandhi, C. Bibbo, M. Pinzur, and S. S. Lin, “The role of platelet-rich plasma in foot and ankle surgery,” Foot and Ankle Clinics, vol. 10, no. 4, pp. 621–637, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Slesaczeck, H. Paetzold, T. Nanning et al., “Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report,” Therapeutic Advances in Endocrinology and Metabolism, vol. 3, no. 2, pp. 75–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. E. J. Dougherty, “An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers,” Advances in Skin & Wound Care, vol. 21, no. 12, pp. 568–575, 2008. View at Google Scholar · View at Scopus
  104. S. E. Lynch, R. C. Williams, A. M. Polson et al., “A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration,” Journal of Clinical Periodontology, vol. 16, no. 8, pp. 545–548, 1989. View at Google Scholar · View at Scopus
  105. E. K. LeGrand, J. F. Burke, D. E. Costa, and T. C. Kiorpes, “Dose responsive effects of PDGF-BB, PDGF-AA, EGF, and bFGF on granulation tissue in a guinea pig partial thickness skin excision model,” Growth Factors, vol. 8, no. 4, pp. 307–314, 1993. View at Google Scholar · View at Scopus
  106. C. H. Heldin and B. Westermark, “Mechanism of action and in vivo role of platelet-derived growth factor,” Physiological Reviews, vol. 79, no. 4, pp. 1283–1316, 1999. View at Google Scholar · View at Scopus
  107. C. P. Pavlovich, M. Battiwalla, M. E. Rick, and M. M. Walther, “Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy,” Journal of Urology, vol. 165, no. 5, article 1617, 2001. View at Google Scholar · View at Scopus
  108. J. Doupis and A. Veves, “Classification, diagnosis, and treatment of diabetic foot ulcers,” Wounds, vol. 20, no. 5, pp. 117–128, 2008. View at Google Scholar · View at Scopus
  109. K. Alexiadou and J. Doupis, “Management of diabetic foot ulcers,” Diabetes Therapy, vol. 3, no. 1, article 4, 2012. View at Publisher · View at Google Scholar
  110. G. Y. Li, J.M. Yin, H. Ding, W. T. Jia, and C. Q. Zhang, “Efficacy of leukocyte-and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model,” Journal of Orthopaedic Research, vol. 31, no. 6, pp. 949–956, 2013. View at Publisher · View at Google Scholar